Navigation Links
NYSCF scientists develop new protocol to ready induced pluripotent stem cell clinical application
Date:4/3/2013

NEW YORK, NY (April 3, 2013) A team of New York Stem Cell Foundation (NYSCF) Research Institute scientists led by David Kahler, PhD, NYSCF Director of Laboratory Automation, have developed a new way to generate induced pluripotent stem (iPS) cell lines from human fibroblasts, acquired from both healthy and diseased donors. Reported in PLOS ONE, this cell-sorting method consistently selects the highest quality, standardized iPS cells, representing a major step forward for drug discovery and the development of cell therapies.

Employing a breakthrough method developed by 2012 Nobel laureate Shinya Yamanaka, MD, PhD, adult cells are "reprogrammed" or reverted to an embryonic-like state, commonly through viral infection. Reprogramming is a dynamic process, resulting in a mixture of fully reprogrammed iPS cells, partially reprogrammed cells, and residual adult cells. Previous protocols to select promising fully reprogrammed cells rely primarily on judging stem cell colonies by eye through a microscope.

Cell colonies selected by qualitative measures could include partially reprogrammed cells, a major concern for clinical applications of cell therapies because these cells could become any other cell type in a patient following transplantation. Additionally for drug efficacy assays and toxicity investigations on iPS cells, heterogeneous cell populations can mar the response of representative iPS cell lines.

The NYSCF scientists developed a quantitative protocol, optimized over three and a half years, in order to consistently harvest early-reprogrammed cells. Using fluorescence activated cell sorting (FACS), fully reprogrammed cells were identified by two specific proteins, or pluripotency markers. The group then looked at third marker that is expressed by partially reprogrammed or adult cells, and they then negatively selected against these cells to obtain only fully reprogrammed cells.

"To date, this protocol has enabled our
'/>"/>

Contact: David McKeon
dmckeon@nyscf.org
212-365-7440
New York Stem Cell Foundation
Source:Eurekalert

Page: 1 2

Related biology news :

1. NYSCF scientists develop 3-D stem cell culture technique to better understand Alzheimers disease
2. Scientists find government justification of new environmental policy unfounded
3. UGA discovery may allow scientists to make fuel from CO2 in the atmosphere
4. UT MD Anderson scientists uncover the nuclear life of actin
5. Scientists awarded £3M to study the way Northwest European seas absorb carbon
6. Scientists reveal quirky feature of Lyme disease bacteria
7. Scientists create new tools for battling secondhand smoke
8. Academy scientists receive top honors for long-term research and training initiatives in Mongolia
9. Scientists discover reasons behind snakes shrinking heads
10. U of T scientists map genome that causes Dutch Elm Disease
11. Scientists discover novel chemical that controls cell behavior
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2015)... Conn. , Feb. 23, 2015 NXT-ID, ... or the "Company"), a biometric authentication company focused on ... has filed provisional patent 62114357 for DISTRIBUTED ... this patent, NXT-ID introduces a new groundbreaking payment method. ... the payment account may only be accessed if both ...
(Date:2/18/2015)... , Feb. 18, 2015  Cepheid (NASDAQ: ... at the following conferences, and invited investors to participate via ... Boston, MA Tuesday, March 3, 2015 at ... Conference, Orlando, FL Wednesday, March 4, ... Webcasts To access the live webcasts for these events, please ...
(Date:2/12/2015)...   MedNet Solutions , a global life ... systems, has recently bolstered its iMedNet™ ... iMedNet as the eClinical solution of ... consultants.  Building on the Program,s existing benefits (including ... co-marketing opportunities), MedNet,s new and improved program provides ...
Breaking Biology News(10 mins):NXT-ID Patents Voice Directed Payments 2NXT-ID Patents Voice Directed Payments 3Cepheid to Webcast Upcoming Financial Presentations 2MedNet Solutions Announces Key Enhancements To Its iMedNet Partner Program 2
... described February 8 in an advance online publication of ... the elegant dance that viral proteins perform to create ... and disease, say researchers. While the virus they studied, ... and HIV are also known to assemble an "intermediary" ...
... Waste and Generate Energy from Waste BiomassATLANTA, Feb. ... the diversified renewable energy company, Global Energy Holdings ... execution of a definitive agreement to acquire Cherokee ... processor, WoodTech, LLC, and affiliated entities. Closing ...
... Early career scientists will leave the lab ... effective teaching, sharpening their skills at workshops held ... partners. As enrollment in science majors grows, ... approach in favor of inquiry-based learning, according to ...
Cached Biology News:Scripps scientists create first crystal structure of an intermediate particle in virus assembly 2Scripps scientists create first crystal structure of an intermediate particle in virus assembly 3Global Energy Systems to Acquire WoodTech, LLC, and Affiliated Entities 2Global Energy Systems to Acquire WoodTech, LLC, and Affiliated Entities 3NSF-funded workshops help young researchers teach science 2
(Date:3/5/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/4ld5nw/mature_biotech ... Biotech Outlook 2015: New Therapy Ventures Pave the Way ... All biotech companies - Gilead (GILD), Amgen (AMGN), ... have given a positive return and hence increased the ... to select therapy/niche indication where the high treatment cost ...
(Date:3/5/2015)... 05, 2015 RMI ... chronic orthopedic conditions such as meniscal tears, ACL ... and joint pain due to degenerative conditions like ... orthopedic surgeries to promote better post-surgical outcomes. , ... nearly pain-free bone marrow harvesting with two complimentary ...
(Date:3/4/2015)... 2015  Brooklyn residents now have a new place ... and injuries. Nunzio Saulle , M.D., a board-certified ... his NJS Physical Medicine and Rehabilitation (PM&R) practice in ... 5, 2015. Health Plus Management, LLC is managing the ... 1178 Flatbush Avenue. This new PM&R practice will treat ...
(Date:3/4/2015)... March 4, 2015 /CNW/ - Resverlogix Corp. (TSX:RVX) ... completed a collaborative research program with Emerald ... Fast Collective Evolution Technology (FACET), Emerald Logic ... measurements obtained from each of 798 patients ... clinical trials ASSERT, SUSTAIN and ASSURE. The ...
Breaking Biology Technology:Mature Biotech Outlook 2015: New Therapy Ventures Pave the Way for Success 2Mature Biotech Outlook 2015: New Therapy Ventures Pave the Way for Success 3Riordan-McKenna Institute of Regenerative Orthopedics and Stem Cell Therapy Announces Open House in Southlake, Texas on Friday, March 6th from 5:30 pm to 7:30 pm. 2Riordan-McKenna Institute of Regenerative Orthopedics and Stem Cell Therapy Announces Open House in Southlake, Texas on Friday, March 6th from 5:30 pm to 7:30 pm. 3Riordan-McKenna Institute of Regenerative Orthopedics and Stem Cell Therapy Announces Open House in Southlake, Texas on Friday, March 6th from 5:30 pm to 7:30 pm. 4Riordan-McKenna Institute of Regenerative Orthopedics and Stem Cell Therapy Announces Open House in Southlake, Texas on Friday, March 6th from 5:30 pm to 7:30 pm. 5NJS Physical Medicine & Rehabilitation Opening on Flatbush Avenue, Brooklyn, NY 2Resverlogix Collaborates with Emerald Logic to Identify Factors Driving Drug Response and Efficacy in Phase 2 Program 2Resverlogix Collaborates with Emerald Logic to Identify Factors Driving Drug Response and Efficacy in Phase 2 Program 3Resverlogix Collaborates with Emerald Logic to Identify Factors Driving Drug Response and Efficacy in Phase 2 Program 4
... Type 1 diabetes is caused by the body,s own ... requires daily injections of insulin to regulate the patient,s ... Central,s open access journal BMC Medicine uses ... own T cells and consequently restart pancreatic function reducing ...
... This release is available in Spanish . ... joint CSIC-UPV/EHU center) and the Donostia International Physics Center (DIPC), ... and the United States, was recently invited to write a ... journal Reviews of Modern Physics of the American ...
... 9, 2012  Neuralstem, Inc. (NYSE Amex: CUR ... present at the 2012 Biotech Showcase in San Francisco ... on the Therapeutic Focus Panel entitled, "Neurodegenerative Disease, Ophthalmology ... Medicine (ARM) Insight Track. Garr will also present a ...
Cached Biology Technology:Smaller and more powerful electronics requires the understanding of 'quantum jamming' physics 2Neuralstem President and CEO to Update Ongoing ALS and NSI-189/Major Depressive Disorder Trials at 2012 Biotech Showcase 2Neuralstem President and CEO to Update Ongoing ALS and NSI-189/Major Depressive Disorder Trials at 2012 Biotech Showcase 3
... high quality whole genome sequencing service. Our ... allow even the smallest of laboratories to ... features which set our whole genome sequencing ... strategies, proprietary assembly software, rapid project turnaround ...
Sequencing and primer design rolled into one. Just give us your clone and a reference sequence, and we'll do the rest. Single-strand or double-strand coverage. Guaranteed results....
...
... Mynox is the first biological ... killing them, and not just ... the only anti-mycoplasma agent that ... virus stocks directly. The cytotoxicity ...
Biology Products: